发明申请
- 专利标题： TRICYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS
- 专利标题（中）： 三元化合物，组合物和方法
-
申请号： US13333104申请日： 2011-12-21
-
公开(公告)号： US20120095062A1公开(公告)日： 2012-04-19
- 发明人: Hengmiao (Henry) CHENG , Xiao HU , Kenvin D. JEROME , Mark OBUKOWICZ , Lisa OLSON , Paul V. RUCKER , Ronald Keith WEBBER
- 申请人： Hengmiao (Henry) CHENG , Xiao HU , Kenvin D. JEROME , Mark OBUKOWICZ , Lisa OLSON , Paul V. RUCKER , Ronald Keith WEBBER
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; A61P11/06 ; A61P1/00 ; A61P19/02 ; A61P25/24 ; C12N5/071 ; A61P27/02 ; A61P11/00 ; A61P37/06 ; A61P17/00 ; A61P25/00 ; A61P29/00 ; A61P25/28
摘要：
The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
公开/授权文献
- US08445520B2 Tricyclic compounds, compositions, and methods 公开/授权日：2013-05-21